Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Amir Asri kojabad"'
Autor:
Seyed Sadegh Eslami, Davod Jafari, Abbas Ghotaslou, Moein Amoupour, Amir Asri Kojabad, Rasool Jafari, Navid Mousazadeh, Parastoo Tarighi, Majid Sadeghizadeh
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 13, Iss 3, Pp 539-550 (2023)
Purpose: Chemotherapy drugs used to treat lung cancer are associated with drug resistance and severe side effects. There have been rising demands for new therapeutic candidates and novel approaches, including combination therapy. Here, we aimed to in
Externí odkaz:
https://doaj.org/article/ab7ce32c3b9641158914b3954253cbd6
Publikováno v:
Biotechnology Reports, Vol 38, Iss , Pp e00792- (2023)
Background: HIV-1-derived lentiviral vectors (LVs) are capable of transducing human cells by integrating the transgene into the host genome. In order to do that, LVs should have enough time and space to interact with the surface of the target cells.
Externí odkaz:
https://doaj.org/article/61cf6f15fac54afaba4cfce81f23da97
Autor:
masoud zare shehneh, seyed mehdi kalantar, Mohammad Hasan Sheikhha, amir asri kojabad, bibi fatemeh Haghiralsadat
Publikováno v:
Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, Vol 27, Iss 1, Pp 1175-1186 (2019)
Introdution: Nanotechnology introduced new methods to chemotherapy drugs delivery into cancer cells to reduce the side effect of drugs it increases the quality of cancer treatment and reduces the side effects of chemotherapy. . In this study, differe
Externí odkaz:
https://doaj.org/article/a0957cc5dd3449fa9fcd89a3046ce91a
Publikováno v:
Biosensors, Vol 11, Iss 10, p 394 (2021)
Globally, non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths. Despite advancements in chemotherapy and targeted therapies, the 5-year survival rate has remained at 16% for the past forty years. Minimal residual disease (MRD) is
Externí odkaz:
https://doaj.org/article/9d98f12ba47447049b0d37bd921596f3
Autor:
Raziyeh Mansurabadi, Saeid Abroun, Abass Hajifathali, Amir Asri Kojabad, Amir Atashi, Mansoureh Haghighi
Publikováno v:
Cell Journal, Vol 19, Iss supp1, Pp 27-36 (2017)
Objective Multiple Myeloma (MM) is a heterogeneous cytogenetic disorder in which clonal plasma cells proliferate in the bone marrow (BM) and cause bone destruction. The BM microenvironment plays a crucial role in pathogenesis of this disease, and me
Externí odkaz:
https://doaj.org/article/c85c929794e94ecdb6a4d7bb52860877
Publikováno v:
Cytotechnology. 75:195-206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e38bd525bae3f35cb16e871149ad5355
https://doi.org/10.1007/s10616-022-00564-w
https://doi.org/10.1007/s10616-022-00564-w
Publikováno v:
Indian Journal of Hematology and Blood Transfusion. 39:173-182
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caf8e459514e9f03f46e20e5b0dcb0bc
https://doi.org/10.1007/s12288-022-01576-4
https://doi.org/10.1007/s12288-022-01576-4
Autor:
Amir Amani, Mehdi Barati, Saeid Barzegar, Maryam Mohammadi Najafabadi, Javad Hashemi, Ali Akbar Pourfathollah, Mahsa Rahgoshay, Amir Asri Kojabad, Rima Manafi Shabestari, Majid Safa, Mohammad Reza Rezvany, Farhad Zaker, Alireza Abbaspour
Publikováno v:
Biotechnology and Applied Biochemistry. 69:1712-1722
Oxidative damage by free radicals has a negative effect on blood quality during storage. Antioxidant nanoparticles can prevent oxidative stress. We use SOD-CAT-Alb-PEG-PLGA- nanoparticles to reduce the effects of oxidative stress in blood storage. El
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1b0204f846f4d3486288e2fa34c01e9
https://doi.org/10.1002/bab.2240
https://doi.org/10.1002/bab.2240
Autor:
Seyed Sadegh Eslami, Davod Jafari, Abbas Ghotaslou, Moein Amoupour, Amir Asri Kojabad, Rasool Jafari, Navid Mousazadeh, Parastoo Tarighi, Majid Sadeghizadeh
Publikováno v:
Advanced Pharmaceutical Bulletin.
Purpose: Chemotherapy drugs used to treat lung cancer are associated with drug resistance and severe side effects. There have been rising demands for new therapeutic candidates and novel approaches, including combination therapy. Here, we aimed to in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f987bc8b06c01c10162a9a3ca681c14
https://doi.org/10.34172/apb.2023.050
https://doi.org/10.34172/apb.2023.050
Autor:
Mohammad Hasan Sheikhha, Bibi Fatemeh Haghiralsadat, Masoud Zare Shehneh, Seyed Mehdi Kalantar, amir asri kojabad
Publikováno v:
Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, Vol 27, Iss 1, Pp 1175-1186 (2019)
Introdution: Nanotechnology introduced new methods to chemotherapy drugs delivery into cancer cells to reduce the side effect of drugs it increases the quality of cancer treatment and reduces the side effects of chemotherapy. . In this study, differe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cb3ec1a0e28c3f69203d9e149910103
http://jssu.ssu.ac.ir/browse.php?a_code=A-10-3620-1&slc_lang=en&sid=1
http://jssu.ssu.ac.ir/browse.php?a_code=A-10-3620-1&slc_lang=en&sid=1